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Around a quarter of patients with pre-existing cardiovascular disease experience myocardial 
infarction (MI) during ICU care, which is usually unrecognized in routine care and results 
predominantly from oxygen supply-demand imbalance (type 2 MI). Both myocardial injury 
(isolated troponin elevation) and MI are associated with worse short and long-term survival, 
and MI may be on the causal pathway between acute physiological derangement and 
mortality.  
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Abstract: 
Purpose  
To establish the incidence of myocardial infarction (MI) in ICU patients with co-existing 
cardiovascular disease (CVD), and explore its association with long-term survival. 
Methods: 
In a multi-centre prospective cohort study in 11 UK ICUs we enrolled 273 critically ill 
patients with co-existing CVD. We measured troponin I (cTnI) with a high sensitivity assay 
for ten days; ECGs were done daily for five days and analysed by blinded cardiologists for 
dynamic changes. Data were combined to diagnose myocardial ‘infarction’, ‘injury’ or ‘no 
injury’ according to the third universal definition of MI. Patients were followed-up for six 
months. Regression and mediation analyses were used to explore relationships between acute 
physiological derangements, MI, and mortality. 
Results: 
cTnI was detected in all patients with a rise/fall pattern consistent with an acute hit. In 73% of 
patients this peaked on days 1-3 (median 114ng/l (1st,3rd quartiles: 27, 393). Serial ECGs 
indicated 24.2% (n=66) of patients experienced MI, but >95% were unrecognized by clinical 
teams. Type 2 MI was the most likely aetiology in all cases. A further 46.1% (n=126) 
experienced injury (no ECG changes). Injury and MI were both associated with six month 
mortality (reference: no injury): OR injury 2.28 (95% CI 1.06-4.92, p=0.035), OR MI 2.70 
(95% CI 1.11-6.55 p=0.028). Mediation analysis suggested MI partially mediated the 
relationship between acute physiological derangement and six month mortality (p=0.002) 
suggesting a possible causal association. 
Conclusions: 
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Undiagnosed MI occurs in around a quarter of critically ill patients with co-existing CVD and 
is associated with lower long-term survival.  
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Around 20-30% of adult ICU admissions have pre-existing cardiovascular disease (CVD) [1, 
2]. These patients are at risk of myocardial ischaemia during acute illness as a result of 
cardiovascular stress and reduced coronary oxygen delivery. 
Diagnosing myocardial infarction (MI) is difficult in critically ill patients. The third universal 
definition of MI requires evidence of myocardial necrosis (elevation of myocardial injury 
biomarkers such as troponin), together with clinical symptoms, ischaemic ECG changes, 
regional wall motion abnormalities on echocardiography, or evidence of coronary thrombus 
[3]. MI is further categorized into Type 1 (plaque rupture) and Type 2 (oxygen supply-
demand imbalance). Myocardial injury is isolated troponin elevation secondary to cardiac 
ischaemia. Troponin elevation is also known to result from other aetiologies including sepsis 
[4], pulmonary embolism [5], acute intracerebral pathology [6], and comorbidities such as 
COPD [7] and renal failure [8].In intensive care (ICU) patients, sedation and altered 
consciousness make application of the universal definition difficult.  
In large studies of non-cardiac surgery myocardial injury is independently associated with 
worse outcomes [9, 10]. Furthermore, both type 2 MI and injury are associated with worse 
outcomes than type 1 MI [11-13]. Although some previous studies have measured troponins 
in ICU patient cohorts, no large studies have systematically used the universal definition to 
estimate myocardial injury and infarction events [2, 14, 15]. This is especially relevant to 
critically ill patients with pre-existing CVD, who are at greater risk due to established 
coronary artery lesions. It is also unclear whether myocardial injury or infarction are causally 
related to higher mortality, rather than simply associated with more severe illness. 
Understanding whether this association is, at least in part, causal has potential clinical 
relevance because, particularly for type 2 MI, it may justify interventions to optimise 
myocardial oxygen supply-demand balance such as anaemia correction or cardiovascular 
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manipulation. Current uncertainty is highlighted by the wide variation in clinical practice in 
response to troponin elevation between clinicians [16].  
Our aim was to establish the incidence of myocardial injury and MI during ICU care 
according to the third universal definition in patients admitted with non-cardiac diagnoses but 
with known pre-existing CVD, and explore whether a causal relationship exists between 
acute physiological derangement, myocardial injury and MI, and six month mortality. 
 
Methods 
Study Design and setting 
TROPICCAL (TROPonin I in Cardiovascular patients in CriticAL care, UKCRN 19253) was 
a prospective cohort study in 11 UK ICUs. Ethical approval was by Scotland A Research 
Ethics Committee, and Newcastle and North Tyneside Ethics Committees. 
Participants 
Inclusion criteria were critically ill adults with pre-existing CVD requiring admission to ICU. 
CVD was defined as any combination of: chronic cardiac disease, peripheral vascular disease, 
previous transient ischaemic attack or cerebrovascular accident, age ≥75yrs with diabetes or 
hypertension, or previous myocardial infarction or unstable angina (table E1). Patients with 
new ACS were excluded if this was the primary diagnosis. Patients or relatives were 
approached for consent depending on their capacity.  
Data collection  
We collected baseline demographic data and daily information for ten days regarding illness 
severity/organ support, and routine blood tests (see eSupplement). Daily troponin I (cTnI) 
was measured using the ARCHITECT STAT high-sensitive troponin I assay (Abbott 
7 
 
Diagnostics, Illinois, USA), a two-step immunoassay using chemiluminescent microparticle 
(CMIA) technology. The limit of detection was 1.2 ng/l, with an upper reference limit (99th 
centile) of 34 ng/L in men and 16 ng/L in women [17]. The co-efficient of variation is 10% at 
6 ng/l [18] (see eSupplement). Clinicians were blinded to study cTnI data, but could order 
cardiac biomarkers at clinical discretion.  
Daily ECGs were performed for up to five days post-admission. ECG interpretation was 
performed by cardiology research fellows, each with over ten years postgraduate experience, 
blinded to clinical information and cTnI results, for the following features: ST 
elevation/LBBB, ST depression, T wave inversion, new Q waves, RBBB (see eSupplement). 
Cardiologists also reported, as a binary outcome, whether serial ECGs indicated dynamic 
changes consistent with acute myocardial ischaemia.   
Outcomes 
Main outcomes were myocardial injury/infarction category, and 6 month mortality. Other 
outcomes were duration of mechanical ventilation, and length of ICU and hospital stay. MI 
was defined as TnI above the sex-specific upper reference limit with ≥20% rise and/or fall in 
cTnI concentrations,  with evidence of dynamic ECG abnormalities suggesting ischaemia. 
Acute myocardial injury was defined as ≥20% rise and/or fall in cTnI, without ECG signs of 
ischaemia. Chronic myocardial injury was defined as a persistently elevated cTnI (<20% 
change) with no evidence of ischaemia. Patients in whom cTnI remained within the reference 
range and had no signs of ischaemia were defined as no injury [3]. Components of the SOFA 
score during the 24 hours preceding MI were used to qualitatively assess the likelihood of 
type 1 versus 2 aetiology.  
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Statistical analyses: 
Myocardial injury and MI data: Data were analyzed using R (R Core Team v3.3.2, Vienna, 
Austria) [19]. Statistical significance was set at p=0.05. All tests were 2-sided. We presented 
continuous data as mean (95% CI), or median (IQR) if non-normally distributed. Binary data 
were presented as frequency (%).  For univariate comparisons, we used the Student t test, 
ANOVA, Mann Whitney U, or Kruskal-Wallis test according to data distribution. Categorical 
data were compared using Fisher’s exact test.  
Relationship with mortality: We plotted unadjusted Kaplan Meier survival curves and 
compared group outcomes with the log rank test. As an exploratory analysis and to explore 
and illustrate the possible importance of baseline illness severity, we compared mortality 
outcomes for patients with higher versus lower acute physiological scores (APS, the acute 
physiological component for APACHE II scores) by dichotomizing the population using the 
median APS score. To further explore possible causal mechanisms between APS 
(“exposure”), MI (“mediator”) and mortality at six months (“outcome”) we undertook a 
mediation analysis [20] (see Figure E1). For this, we used a binomial (“probit”) model using 
the mediation R package (see eSupplement for further explanation) [21]. We included 
variables with significant univariable association with mortality, and those considered 
clinically important.  
We explored the association of myocardial injury category with six month mortality using 
multivariable logistic regression, including the same variables. APS was excluded from this 
model due to the potential for adjusting for a mediator. 
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Results 
Between 15th February 2015 and 30th June 2016 we recruited 279 patients in 11 different UK 
National Health Service (NHS) regions (Consort diagram, figure E2; table E2). The 
prevalence of CVD among ICU admissions was 23.4% (table E2). Cohort characteristics are 
summarized in table 1. The majority of patients (91.4%) were on long-term medication for 
CVD (table E3).  
Pattern of cTnI release 
All patients had detectable cTnI during ICU stay. There was a wide range of cTnI at 
admission (median (1st, 3rd quartile, range) 36ng/l (13, 140, 1-45400ng/l)), and peak cTnI 
(median 114ng/l (27, 393; 3-58820ng/l) (figure 1). 64 (84.2%) women and 130 (66.0%) men 
had peak cTnI over the sex-specific diagnostic threshold for diagnosis of myocardial 
infarction or injury (overall total n=194 (71.1%), figure 1A). Peak cTnI for most patients 
(73%) occurred within 2-3 days of admission to ICU (figure 1B). Virtually all patients had a 
dynamic rise and fall pattern of cTnI release consistent with acute myocardial injury, which 
was apparent across all quartiles of peak cTnI (figure 2). Among the 37 (13%) of patients 
who died in ICU, 33 (89%) had dynamic rise and fall patterns before they died and four 
patients died on the day of peak cTnI. Patterns of TnI rise and fall were similar across 
severity of Acute Kidney Injury groups (figure E4, online supplement). 
ECG abnormalities 
There was excellent agreement between cardiologists regarding the presence/absence of acute 
myocardial ischaemia on serial ECGs (kappa 0.89, table E4). On admission to ICU 132 
(47.3%) patients had a normal ECG (figure E3) of whom 19 (14.4%) had subsequent 
dynamic ECG changes consistent with acute myocardial ischaemia. Ninety one patients 
(32.6%) had an abnormal ECG on admission, of whom 44 (48.3%) had no subsequent 
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changes suggesting chronic abnormalities, but 47 (51.6%) had evolving changes consistent 
with acute myocardial ischaemia. In 24 patients (8.6%) no baseline ECG was available of 
whom 22 had no subsequent ECG abnormalities and two demonstrated dynamic changes 
consistent with acute myocardial ischaemia. Overall, 68 patients (24.4%) had dynamic 
abnormalities on serial ECG testing considered indicative of acute myocardial ischaemia.  
Incidence of infarction and injury  
Sixty eight patients fulfilled the universal definition for MI (24.4%, 95% CI 19.2% to 
29.7%); 126 for acute injury (46.1%, 95% CI 40.1% to 52.3%); and 84 demonstrated no 
injury (30.7%, 95% CI 25.3% to 36.6%) (figure 3). The median peak cTnI for MI was 
significantly higher than for injury (infarction 375ng/l vs injury 138ng/l, p<0.001). Only 
4.3% (n=12) of patients were diagnosed with MI by the clinical teams, of whom only three 
fulfilled the universal definition of MI. Twenty four percent (N=65) of the patients therefore 
experienced clinically undiagnosed MI according to the universal definition. 
Physiological data relevant to coronary oxygen supply-demand imbalance during the 24 
hours preceding the peak TnI for each patient suggested that type 2 MI was the most likely 
mechanism in all patients (table E5). Specifically, all patients (n=68) were receiving medium 
or high dose vasoactive drugs (57% (n=39) high dose) but, despite this, 37% (n=25) had a 
lowest MAP ≤60mmHg. Sixty percent (n=41) had a highest lactate ≥2mmol/l and 40% 
(n=27) had a lowest haemoglobin ≤90g/l.  
Mortality, duration of mechanical ventilation, and length of stay  
Survival curves according to injury category are shown in figure 4. Patients experiencing 
infarction and injury had lower survival over six months than patients with no injury 
(P=0.003; Figure 4A; Table E6), but without statistically significant differences between the 
injury and infarction groups. When dichotomised by median APS (median=13), patterns of 
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survival were different between the injury/infarction groups.  For APS>13 (greater 
physiological derangement) there were differences across the groups (P=0.042), but injury 
and MI groups had similar survival curves. However, for APS≤13 (less physiological 
derangement), differences between groups were more marked (p=0.005) and patients 
experiencing MI had higher mortality than those in both injury and no injury groups (Figure 
4B, 4C). The interaction between APS and MI was significant (p=0.035) suggesting that the 
relationship between injury/infarction category and mortality may differ according to the 
early severity of physiological derangement. TnI release was lower in the Injury patients 
versus the MI patients for the lower APS sub-group, but substantially higher in the Injury 
patient (and similar to MI patients) in the higher APS sub-group (figure E5). 
Length of ICU and hospital stay was similar across categories (table E6), but patients 
experiencing MI had longer median (1st, 3rd quartile; range) duration of MV than patients 
with injury, or no injury (MI 4 days (2, 7; 0-39); injury 2 days (0, 5; 0-31); no injury (1 day 
(0, 4; 0-33); P=0.001 infarction versus injury). 
Independent and potential causal relationship between injury, MI, and mortality 
The mediation model suggested that APS (“Exposure”, Estimate 0.114, p=0.0005) and MI 
(“Mediator”, Estimate 2.50, p=0.006) were significantly associated with mortality at six 
months (“Outcome”). Mediation analysis estimated that 63.0% of the effect on six month 
mortality from APS lay on the direct route (Average Direct Effect: b=0.006, 95% CI 0.003 to 
0.010, p=0.001), but 37.0% of the effect was mediated through MI (Average Causal 
Mediation Effect: b=0.0038, 95% CI 0.001 to 0.007, p=<0.001, Figure E6). This confirmed 
the expected significant relationship between APS and mortality, but suggested that the 
occurrence of an MI was on a causal pathway for part of this relationship. 
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There was a strong univariable association between six month mortality and injury/infarction 
category (Ref: no injury, Injury OR 2.96 (95% CI 1.45, 6.03), MI OR 3.35 (95% CI 1.51, 
7.43). This persisted after adjustment for confounders: OR injury 2.28 (95% CI 1.06 to 4.92), 
Infarction 2.70 (95% CI 1.11 to 6.55) (table E8). 
Discussion 
We found cTnI was detectable in all critically ill patients admitted to ICUs with pre-existing 
CVD, and consistently demonstrated a rise and fall pattern in keeping with an ‘acute hit’ 
mechanism of injury. Detailed prospective classification of myocardial injury and infarction 
indicated an incidence of MI of 24.2%, with >95% undiagnosed by clinical teams. The 
physiological status of all patients with MI suggested potential coronary supply/demand 
imbalance, and likely type 2 MI rather than plaque ruptures or other coronary occlusive 
events. Both myocardial injury and infarction were associated with higher six month 
mortality, which in adjusted logistic regression suggested an independent association. 
Exploratory analyses of sub-groups with greater or lesser acute physiological derangement 
suggested the association between MI and mortality may be strongest among patients with 
less acute physiological derangement. Importantly, a mediation analysis exploring whether 
MI mediates part of the relationship between APS and mortality suggested it did contribute 
on the causal pathway.  
The prevalence of CVD was 23.4% in this study, which is similar to previous studies [1, 2] 
and highlights the importance of understanding whether ICU care should be modified for this 
population. Although peak cTnI concentrations varied widely, in virtually all patients there 
was a characteristic rise/fall pattern suggesting an acute mechanism of injury and the patterns 
cTnI were broadly similar to the log linear decrease seen post primary angioplasty for ST 
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elevation MI. This suggests an acute ‘hit’ within the first 2-3 days of admission in most 
patients [22]. Of relevance, patterns were similar across all grades of renal injury. 
The blinded systematic approach by cardiologists used to discriminate injury from MI has 
been shown to result in higher diagnostic agreement compared with non-cardiologist 
interpretation [23], and demonstrated fair to good agreement for ST elevation and ST 
depression. The poorer reliability of T-wave inversion is also consistent with previous 
literature suggesting this is a less valid measure of ischaemia [24-26]. We used dynamic 
ischaemia using all ECGs to define MI, which had high reliability. This was important 
because a third of patients had abnormal baseline ECGs, of whom only one half experienced 
dynamic changes. Although the absence of clinical symptoms made temporal relationships 
between ECG changes and troponin release difficult to interpret, we observed closely 
concurrent changes in patients within the first 2-3 days in the majority of patients, suggesting 
we achieved high diagnostic accuracy for injury and MI. This was in contrast with non-
systematic approaches by clinicians which resulted in very low identification of MI. Only a 
quarter of patients diagnosed clinically with MI fulfilled the universal definition.  
Both injury and MI were significantly associated with six month mortality, which is 
consistent with published literature for troponin in both perioperative and critical care 
practice where elevated troponin levels are associated with greater mortality irrespective of 
the etiology of release [2, 14, 27-30]. Only two previous ICU studies analyzed both troponin 
and ECG data concurrently; both were in general ICU populations rather than restricted to 
patients with co-existing CVD [2, 15]. Lim et al found 50% of 103 patients had an elevated 
TnT (threshold of 40ng/l) [15], of whom half were judged to have had an MI, and more than 
30% of these a Type 2 MI. However, classification for Type 2 MI required no history of 
coronary artery disease or risk factors. Ostermann et al found the majority of critically ill 
patients (84%, total study n=144) had a TnT rise (threshold 15ng/l); 41% met criteria for MI, 
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of whom only 20% were recognized clinically. In both studies patients with TnT increase had 
higher mortality. Our multicentre study restricted to patients with pre-existing CVD reports 
the most detailed evaluation to date, and confirms high rates of unrecognized MI in this 
population (around a quarter of patients).  
To address the key question of whether myocardial injury or infarction have any causal 
association with mortality, we used mediation analysis. Our analysis confirmed the expected 
direct effect of acute physiological derangement on mortality, but suggested that around a 
third of this effect may be mediated through MI events. Although we cannot be sure of the 
mechanism of MI, all patients who were diagnosed with MI were on high dose vasopressors 
from a pathophysiological perspective this is consistent with oxygen supply-demand 
imbalance (Type 2 MI). However, inflammation in the critically ill patient may also be 
associated with greater risk of plaque rupture and type 1 MI. A potentially causal relationship 
between MI and mortality supports the hypothesis that interventions to optimize myocardial 
oxygen/supply demand balance might improve outcomes in patients with pre-existing CVD, 
and future randomized trials are likely to be the best way to address this. Our exploratory 
sub-group analysis suggested the association between MI and mortality may interact with 
acute physiological derangement, with greater effects from MI observed in less deranged 
patients. This relationship appeared different for myocardial injury alone. This hypothesis-
generating observation has potential biological plausibility, because mortality attributable to 
new MI may be proportionately greater in patients with less severe illness.  
Strengths of our study include the use of a highly sensitive cTnI assay across a range of ICUs, 
and inclusion of a range of pre-existing CVD categories suggesting generalisability. We also 
had few missing data and complete patient follow up. Our study has several weaknesses. 
Patients may have had further episodes of injury or MI later in their hospital stay, and we 
only captured events during the first 5 days in ICU. We recorded admission cardiac 
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medications, but not whether these were continued or stopped during the ICU admission as 
this was not the aim of the study. Although our study is the largest to date, with a high event 
rate, the power of our analyses was restricted by sample size and could be subject to both 
type I and II error. Due to sample size we dichotomised on median APS score rather than 
reporting in tertiles or quartiles. The mediation analysis allowed novel exploration of possible 
causal mechanisms, but a randomized trial would be needed to know if strategies aimed at 
manipulating physiological variables can prevent MI and improve outcomes. Candidate 
components of an intervention to decrease coronary oxygen-supply imbalance include a more 
liberal transfusion practice, and it is notable that nadir haemoglobin was also independently 
associated with mortality in our analysis. Recent meta-analyses suggest that liberal 
transfusion strategies may decrease MI rates in both patients with CVD [31] and without 
known CVD [32]. The TRICS III trial suggested heterogeneity within the cardiac surgery 
population [33], highlighting further that personalised approaches to transfusion may be 
context specific. Other potential interventions include continuation or initiation of cardiac 
medications. There is substantial clinical uncertainty and practice variation regarding primary 
and secondary interventions for injury and MI in ICU patients [13, 16]. Our data support the 
need for further research to clarify best practice in patients at high risk of MI, such as those 
with pre-existing CVD.  
Conclusion 
In conclusion, we have demonstrated that around a quarter of patients with pre-existing CVD 
experience MI during ICU care, which is usually unrecognised in routine care. Both 
myocardial injury and infarction are associated with worse short and long-term survival, 
andMI may be on the causal pathway between acute physiological derangement and 
mortality. These data support future research to explore whether ICU interventions to reduce 
MI in patients with pre-existing CVD can improve outcomes. 
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Figure legends: 
Figure 1. A) Peak cTnI concentration for each patient (n=273) on a logarithmic scale (blue 
dots are men, red dots are women). Horizontal lines represent the sex-specific upper 
reference limits for men and women with 130/197 (66.0%) men and 64/76 (84.2%) women 
respectively above this threshold. B) Histogram showing the day of peak cTnI concentration 
for all patients (day 1 is the first day of ICU admission).  
Figure 2: Change in cTnI concentrations centred around the peak concentration. Each 
coloured line represents a separate patient. The black line represents the “average” patient 
(the smoothed conditional mean with 95% confidence intervals). A) cTnI concentrations as a 
percentage of the peak concentration in all patients. B) cTnI concentrations stratified into 
quartiles to display the rise and fall pattern across the range of peak cTnI concentrations (Q1 
cTnI <25 ng/l, Q2 cTnI 25-107 ng/l, Q3 cTnI 107-380 ng/l, Q4 cTnI >380ng/l [Q4 on 
logarithmic scale]).  
Figure 3: n=273. Dynamics of peak cTnI by No injury (cTnI<threshold, n=84, 30.7%); Injury 
(cTnI>threshold, no dynamic ECG ischaemia, n=126, 46.1%); Infarction (cTnI elevation + 
dynamic ECG ischaemia, n=66, 24.2%). cTnI is plotted on log10 scale. Box plots represent 
median and IQR. Horizontal dotted line at sex specific thresholds cTnI=16 & 34ng/l. 
Figure 4: Kaplan Meier survival plots, stratified by group (red, no injury; green, acute 
myocardial injury; blue, myocardial infarction). A) All patients, log rank test Chi2= 11.8 
(df=2), p=0.003. B) Patients with Acute Physiological Score >13 (median population value), 
log rank test Chi2=6.4 (df=2), p=0.042. C) Patients with Acute Physiological Score ≤13, log 
rank test Chi2=10.5 (df=2) p=0.005. 
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Table 1: Baseline Characteristics for whole cohort. N=279. Patients can appear in more than 
one CVD category and more than one Chronic cardiac disease category. 
Variable n or mean/median % or SD or IQR 
 279  
Age mean(SD) 72.3 10.9 
Male sex n(%) 200 71.7 
Chronic cardiovascular disease eligibility diagnosis n(%)   
  Acute Coronary Syndrome 22 7.9 
  Cerebrovascular accident/Transient ischaemic attack 42 15.1 
  Peripheral Vascular Disease 55 19.7 
  ≥75 with Diabetes Mellitus/Hypertension 90 32.5 
  Chronic cardiac disease 
         Coronary artery disease 
         Congestive cardiac failure 
         Valvular disease 
         Arrhythmia 
         Hypertensive heart disease 
         Hypercholesterolemic heart disease 
174 
67 
27 
26 
65 
58 
13 
62.4 
38.5 
15.5 
14.9 
37.4 
33.3 
7.5 
ICU admission diagnosis system n(%)  
  Respiratory 65 23.3 
  Cardiovascular 64 22.9 
  Gastrointestinal 84 30.1 
  Neurological 12 4.3 
  Genito-urinary 31 11.1 
  Other 22 7.9 
Comorbidity assessment  
  Apache:   0 233 83.5 
1 36 12.9 
≥2 10 3.6 
Functional comorbidity index score med(IQR) 2 1,3 
Type of admission n(%)  
  Elective Surgical 56 20.1 
  Emergency Surgical 81 29 
  Non-operative 142 50.9 
Severity of Illness in first 24h 
  APACHE II score  18 15,23 
  SOFA score 7 5,10 
  Vasopressors n(%) 104 37.3 
  Mechanical Ventilation n(%) 134 48.2 
  Renal Replacement Therapy n(%) 8 2.9 
  pre ICU Length of Stay (d) med(IQR) 1 0,2 
Haemoglobin at admission g/l med (IQR) 111 93,125 
Troponin at admission ng/l med (min, IQR, max) 26 1, 7 ,56,  2157 
 
  
22 
 
 
Figure 1 
 
Figure 2 
23 
 
 
Figure 3 
 
Figure 4 
